Bank of America Has Lowered Expectations for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its target price decreased by Bank of America from $23.00 to $20.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s target price indicates a potential upside of 30.36% from the stock’s previous […]
